Читать книгу Uric Acid in Chronic Kidney Disease - Группа авторов - Страница 5
ОглавлениеContributions to Nephrology
(Founded 1975 by Geoff rey M. Berlyne)
| _______________________Alejandro Treviño-BecerraUremic and Dialysis ClinicTuxpan 16–104 Col. Roma06760 México City (México) | _______________________Kunitoshi IsekiClinical Research Support CenterTomishiro Central Hospital25 Ueta, TomigusukuOkinawa 901–0243 (Japan) |
Library of Congress Cataloging-in-Publication Data
Title: Uric acid in chronic kidney disease / volume editors, Alejandro Treviño-Becerra, Kunitoshi Iseki.
Other titles: Contributions to nephrology ; v. 192. 0302-5144
Description: Basel ; New York : Karger, [2018] | Series: Contributions to nephrology, ISSN 0302-5144 ; vol. 192 | Includes bibliographical references and indexes.
Identifiers: LCCN 2017057195| ISBN 9783318062502 (hard cover : alk. paper) | ISBN 9783318062519 (e-ISBN)
Subjects: | MESH: Renal Insufficiency, Chronic | Hyperuricemia | Uric Acid--blood | Diabetic Nephropathies | Gout
Classification: LCC RC632.H89 | NLM WJ 342 | DDC 616.3/99--dc23 LC record available at
https://lccn.loc.gov/2017057195
Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and Index Medicus.
Disclaimer. The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the book is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
© Copyright 2018 by S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland)
Printed on acid-free and non-aging paper (ISO 9706)
ISSN 0302–5144
e-ISSN 1662–2782
ISBN 978–3–318–06250–2
e-ISBN 978–3–318–06251–9
